Tragara Pharmaceuticals
Latest round
- Series B
Last raised
- Sep 2013
Total raised
- $56M
Investors
- 7
About Tragara Pharmaceuticals
Tragara Pharmaceuticals, Inc.Tragara Pharmaceuticals, Inc. is dedicated to creating therapies for oncology applications. Founded in 2007, the company is headquartered in Carlsbad, California, US.26 mn.com operates within the domain marketplace, facilitating the buying and selling of internet domains. The company's core service is connecting domain sellers with potential buyers, thereby streamlining the transaction process for digital real estate. Customers include individual entrepreneurs, small businesses, and large corporations looking to establish or enhance their online presence through premium domain names. The platform is designed to assist in identifying valuable domain names that align with a client’s branding needs and market strategy.com is predominantly based on transaction fees generated from domain sales facilitated through its platform. Each sale incurs a service charge, which constitutes the main revenue stream for the company. Transactions typically occur on a B2B basis, where businesses engage directly with the company to purchase or sell domains. Pricing models may vary based on the domain's perceived value, with higher prices for premium or trademarked domains.In November 2016, Tragara Pharmaceuticals, Inc. Upcoming new products are being designed, and the company is targeting growth in North America and Europe, with a strategic focus on launching these initiatives within the next year.
Who invested in Tragara Pharmaceuticals
7 investors across 3 rounds
See all investors in Tragara Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tragara Pharmaceuticals
Who invested in Tragara Pharmaceuticals?
Tragara Pharmaceuticals has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tragara Pharmaceuticals raised?
Tragara Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Tragara Pharmaceuticals last raise money?
Tragara Pharmaceuticals's most recent round on record is a Series B, in Sep 2013.
What does Tragara Pharmaceuticals do?
Tragara Pharmaceuticals is a pharmaceuticals company.
Where is Tragara Pharmaceuticals headquartered?
Tragara Pharmaceuticals is headquartered in Carlsbad, US.
Which VCs invest in companies like Tragara Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Tragara Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Tragara Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.